BUSINESSCipla to Invest €15 Million in Ethris, mRNA-based TherapiesadminDecember 30, 2022December 30, 2022 December 30, 2022December 30, 2022 Cipla’s wholly owned UK arm has contracted in Ethris worth €15 million, a universal leader in transporting mRNAs directly to the respiratory system with administration...